Report: Screening programs in Italy (Italy): Difference between revisions

From Beacon
(Created page with "{{#subobject:Screening programs in Italy |dct:title=Screening programs in Italy |datatype=policymaking }} '''Sponsor, manager or home institution:''' Osservatorio Nazionale Screening; Ministero della Salute. '''Primary purpose:''' Assesses annual cancer screening programs in Italy, indicating substantial participation in mammography and cervical screenings, significant progress in colorectal screening, and disparities in coverage between regions. '''Type of informat...")
 
No edit summary
Line 1: Line 1:
{{#subobject:Screening programs in Italy
{{forpolicymakers}}
|dct:title=Screening programs in Italy
Go back to [[Italy]] page
|datatype=policymaking
}}


'''Sponsor, manager or home institution:''' Osservatorio Nazionale Screening; Ministero della Salute.
'''Sponsor, manager or home institution:''' Osservatorio Nazionale Screening; Ministero della Salute.

Revision as of 15:41, 4 December 2023

Go back to Italy page

Sponsor, manager or home institution: Osservatorio Nazionale Screening; Ministero della Salute.

Primary purpose: Assesses annual cancer screening programs in Italy, indicating substantial participation in mammography and cervical screenings, significant progress in colorectal screening, and disparities in coverage between regions.

Type of information: Effective extent of mammography, cervical and colorectal screening; Participation (%) in screenings according to the country of origin; Waiting times; Invitations; Availability of pre-operative diagnosis; Conservative surgery; Total number of persons invited Number of persons participating in the invitation; Acceptance of the invitation; Number of persons examined in the period; Proportion of persons recalled for further investigation; Benign biopsies; Cancer identification rate; Invasive cancer identification rate; Percentage of conservative surgical treatment in invasive tumors; Mammography performed within the last 2 years; Fecal occult blood test programs - Main results in the two-year period; Programs with Rectosigmoidoscopy; Examination for the prevention of colorectal cancer in the recommended times (%) persons; Lesions with CIN2+ histology identified; Introduction of the human papilloma virus (Hpv) test as a screening test; Preventive test coverage in the last 3 years.

Data level: National and regional level.

Access to information: Access Information [1].